Derivative Instruments and Hedging Activities - Narrative (Details) |
1 Months Ended | 6 Months Ended | |
---|---|---|---|
Feb. 28, 2021
USD ($)
shares
|
Jun. 30, 2021
counterparty
shares
|
Sep. 30, 2020
USD ($)
shares
|
|
Derivative [Line Items] | |||
Number of counterparties | counterparty | 15 | ||
Second Lien Notes | |||
Derivative [Line Items] | |||
Debt instrument aggregate principal amount | $ | $ 300,000,000.0 | ||
September 2020 Warrants | |||
Derivative [Line Items] | |||
Sale of stock, number of shares issued in transaction (in shares) | shares | 5,600,000 | 6,400,000 | |
Derivative liability | $ | $ 134,800,000 | ||
Common Stock | September 2020 Warrants | |||
Derivative [Line Items] | |||
Number of securities called by warrants (in shares) | shares | 7,300,000 |
X | ||||||||||
- Definition Number Of Counterparties No definition available.
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|